Oxford BioMedica plc (OTCMKTS:OXBDF)’s share price hit a new 52-week low on Friday . The stock traded as low as $7.85 and last traded at $7.85, with a volume of 153 shares trading hands. The stock had previously closed at $8.15.
Several brokerages have recently weighed in on OXBDF. Zacks Investment Research upgraded Oxford BioMedica from a “sell” rating to a “hold” rating in a report on Wednesday. HC Wainwright restated a “buy” rating and issued a $14.50 price objective on shares of Oxford BioMedica in a report on Tuesday, May 28th.
The firm has a market capitalization of $535.29 million, a PE ratio of 52.33 and a beta of 0.74. The firm has a fifty day moving average price of $8.70 and a 200 day moving average price of $8.94.
Oxford BioMedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of lentiviral vector and cell therapy products for the treatment of various cancers, Parkinson's, central nervous system disorders, and ocular conditions in Europe and internationally. The company operates through Platform and Product segments.
Featured Article: Bear Market – How and Why They Occur
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.